VITA 34 AG (V3V.DE)
EUR 4.28
(2.88%)
EUR 4.28
(2.88%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.12 EUR | 93.06% |
| 2022 | -1.73 EUR | -158.21% |
| 2021 | -0.67 EUR | -291.43% |
| 2020 | 0.35 EUR | 6.06% |
| 2019 | 0.33 EUR | 65.0% |
| 2018 | 0.20 EUR | 320.51% |
| 2017 | -0.09 EUR | -164.79% |
| 2016 | 0.14 EUR | -78.46% |
| 2015 | 0.65 EUR | 85.71% |
| 2014 | 0.35 EUR | 29.63% |
| 2013 | 0.27 EUR | 235.0% |
| 2012 | -0.20 EUR | -142.55% |
| 2011 | 0.47 EUR | 161.11% |
| 2010 | 0.18 EUR | -18.18% |
| 2009 | 0.22 EUR | 134.92% |
| 2008 | -0.63 EUR | -36.96% |
| 2007 | -0.46 EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.08 EUR | -122.22% |
| 2024 Q1 | -0.04 EUR | -121.43% |
| 2023 Q3 | -0.10 EUR | -32.8% |
| 2023 Q4 | 0.21 EUR | 310.0% |
| 2023 Q1 | -0.19 EUR | 84.43% |
| 2023 FY | - EUR | 93.06% |
| 2023 Q2 | -0.08 EUR | 60.37% |
| 2022 Q2 | -0.29 EUR | -61.11% |
| 2022 FY | - EUR | -158.21% |
| 2022 Q3 | -0.02 EUR | 91.59% |
| 2022 Q4 | -1.22 EUR | -4900.0% |
| 2022 Q1 | -0.18 EUR | 30.77% |
| 2021 Q2 | -0.00 EUR | 64.52% |
| 2021 Q4 | -0.26 EUR | -336.36% |
| 2021 Q3 | 0.11 EUR | 3433.33% |
| 2021 FY | - EUR | -291.43% |
| 2021 Q1 | -0.01 EUR | 88.81% |
| 2020 Q1 | 0.06 EUR | 150.0% |
| 2020 Q4 | -0.08 EUR | -155.4% |
| 2020 Q2 | 0.15 EUR | 150.0% |
| 2020 FY | - EUR | 6.06% |
| 2020 Q3 | 0.15 EUR | 0.0% |
| 2019 Q1 | 0.11 EUR | 304.84% |
| 2019 FY | - EUR | 65.0% |
| 2019 Q2 | 0.14 EUR | 27.27% |
| 2019 Q3 | 0.04 EUR | -71.43% |
| 2019 Q4 | -0.12 EUR | -400.0% |
| 2018 Q2 | 0.06 EUR | -14.29% |
| 2018 Q3 | 0.12 EUR | 100.0% |
| 2018 Q4 | -0.05 EUR | -144.75% |
| 2018 FY | - EUR | 320.51% |
| 2018 Q1 | 0.07 EUR | -63.16% |
| 2017 Q3 | 0.06 EUR | 113.64% |
| 2017 Q1 | 0.10 EUR | 78.25% |
| 2017 FY | - EUR | -164.79% |
| 2017 Q4 | 0.19 EUR | 216.67% |
| 2017 Q2 | -0.44 EUR | -540.0% |
| 2016 FY | - EUR | -78.46% |
| 2016 Q3 | 0.10 EUR | 433.33% |
| 2016 Q4 | 0.06 EUR | -43.9% |
| 2016 Q2 | -0.03 EUR | -409.28% |
| 2016 Q1 | 0.01 EUR | -97.74% |
| 2015 Q4 | 0.43 EUR | 342.39% |
| 2015 Q3 | 0.10 EUR | 149.87% |
| 2015 Q1 | 0.09 EUR | -53.95% |
| 2015 FY | - EUR | 85.71% |
| 2015 Q2 | 0.04 EUR | -55.54% |
| 2014 Q1 | 0.07 EUR | -59.94% |
| 2014 Q2 | -0.02 EUR | -129.37% |
| 2014 Q3 | 0.11 EUR | 650.0% |
| 2014 Q4 | 0.19 EUR | 72.73% |
| 2014 FY | - EUR | 29.63% |
| 2013 Q4 | 0.17 EUR | 149.63% |
| 2013 Q3 | 0.07 EUR | 75.06% |
| 2013 Q2 | 0.04 EUR | 1396.15% |
| 2013 Q1 | 0.00 EUR | 104.86% |
| 2013 FY | - EUR | 235.0% |
| 2012 Q2 | -0.06 EUR | 25.46% |
| 2012 FY | - EUR | -142.55% |
| 2012 Q3 | -0.03 EUR | 49.83% |
| 2012 Q4 | -0.05 EUR | -75.99% |
| 2012 Q1 | -0.08 EUR | -131.27% |
| 2011 Q2 | -0.06 EUR | 49.55% |
| 2011 Q3 | 0.36 EUR | 748.65% |
| 2011 FY | - EUR | 161.11% |
| 2011 Q4 | 0.26 EUR | -27.78% |
| 2011 Q1 | -0.11 EUR | -288.68% |
| 2010 Q2 | -0.03 EUR | -128.7% |
| 2010 Q1 | 0.10 EUR | 24.94% |
| 2010 FY | - EUR | -18.18% |
| 2010 Q4 | 0.06 EUR | 99.66% |
| 2010 Q3 | 0.03 EUR | 204.66% |
| 2009 Q1 | -0.03 EUR | 0.0% |
| 2009 Q3 | 0.15 EUR | 364.4% |
| 2009 FY | - EUR | 134.92% |
| 2009 Q4 | 0.08 EUR | -48.13% |
| 2009 Q2 | 0.03 EUR | 204.53% |
| 2008 Q2 | -0.27 EUR | 0.0% |
| 2008 FY | - EUR | -36.96% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 1.70 EUR | 107.059% |
| Fresenius SE & Co. KGaA | -1.05 EUR | 88.571% |
| LIMES Schlosskliniken AG | 11.58 EUR | 101.036% |
| M1 Kliniken AG | 0.54 EUR | 122.222% |
| Maternus-Kliniken Aktiengesellschaft | -0.68 EUR | 82.353% |
| MEDICLIN Aktiengesellschaft | -0.23 EUR | 47.826% |
| RHÖN-KLINIKUM Aktiengesellschaft | 0.58 EUR | 120.69% |